RECTAL CARCINOMA
Clinical trials for RECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Vaccine-Immunotherapy combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-phase study tested a vaccine (p53MVA) plus the drug pembrolizumab in 11 adults with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the combination is safe and can boost the immune system to attack cancer cells. Participant…
Matched conditions: RECTAL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 16, 2026 23:51 UTC
-
Massive cancer screening trial aims to cut deaths
Prevention OngoingThis study looked at whether screening tests for prostate, lung, colorectal, and ovarian cancers can help find cancer early and reduce deaths. Over 154,000 people aged 55-74 took part. Researchers compared cancer deaths between those who got screened and those who received usual …
Matched conditions: RECTAL CARCINOMA
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 15, 2026 11:53 UTC
-
New study tracks pelvic changes after radiation in women
Knowledge-focused OngoingThis study follows 72 women with pelvic cancers (like cervical or rectal) to see how radiation therapy changes their pelvic health and sexual function over two years. Researchers measure physical changes and ask about symptoms like dryness or pain. The goal is to better understan…
Matched conditions: RECTAL CARCINOMA
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 16, 2026 23:51 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes of a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to standard therapy are enrolled. The goal is to see if targe…
Matched conditions: RECTAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC